Dental implant lead follow-up

Why implant enquiries are a different animal

Most dental follow-up advice — including our own general sequence — is built around an enquiry that decays in days. Implants and full-arch cases break that assumption in four specific ways, and each one changes the sequence design.

• The sum is large enough to require a decision, not a choice. A whitening enquiry is a purchase somebody makes. A full-arch case is a financial commitment on the scale of a car, and people do not make those in a browsing session. The gap between "I want this" and "I am doing this" is measured in weeks or months, and it is not hesitation — it is the normal shape of a decision that size.
• There is nearly always a second decision-maker. A spouse, a partner, an adult child. That person was not on the call, did not attend the consultation, and has questions that the patient will be asked to answer at home from memory. What you send between touches is often being read by someone you have never spoken to.
• Patients consult multiple practices, deliberately and serially. Not three tabs in one evening — three consultations over five weeks, each with a wait for an appointment. Your practice may be first or third, and being first is a weaker advantage here than in short-cycle work, because the patient has not finished gathering information yet.
• Financing frequently is the decision. Not a footnote to it. A patient who wants the treatment, trusts your clinician, and cannot see how to pay for it will simply stop replying — and from the practice's side that is indistinguishable from a lead that lost interest. It is not the same thing at all, and it is recoverable.

The practical consequence: silence in an implant pipeline is a much weaker signal than silence in a routine one. Treating a three-week gap as a dead lead is the most common and most expensive mistake practices make with this case type.

The decision cycle, stage by stage

A long-cycle enquiry moves through recognisable stages, and the reason generic sequences fail is that they send stage-one content to someone who has moved to stage four. Knowing roughly which stage a lead is in is what makes the follow-up useful rather than repetitive.

• Stage 1: working out what the options even are. The patient knows they have a problem and is discovering what the possible approaches are called. They are reading, not comparing providers. Anything that pushes for a booking here lands too early.
• Stage 2: comparing providers. Galleries, reviews, who does the work, how many cases the practice does. This is where the consultation gets booked, and where responsiveness matters most.
• Stage 3: consulting — possibly more than once. They attend yours, and often one or two others. Weeks pass. This is the stage where practices go quiet because there is no obvious next action.
• Stage 4: working out the money. Frequently the longest stage and almost always invisible to the practice. Conversations at home, looking at what is affordable, working out whether it happens this year or next. Nothing you can see is happening, and a great deal is happening.
• Stage 5: timing and commitment. They have decided, and are now solving for when — work, travel, a family event, or their own view of when the money works. A practice that stopped following up at week three is not in this conversation.

The important asymmetry: stages 1 to 3 are visible to you, and stages 4 and 5 mostly are not. The sequence exists to keep the practice present during the invisible part without becoming pressure.

Short-cycle versus long-cycle sequences

Pacing a long sequence

The governing principle is that the gaps get wider. A sequence with a fixed weekly cadence over six months is not a long-cycle sequence; it is a short-cycle sequence stretched, and it reads as nagging by month two. Widening intervals communicate something specific and useful: we are not going anywhere, and we are not going to chase you.

A workable shape, to adapt to your practice rather than to adopt:

• Day 0. Immediate acknowledgement of the enquiry with a real next step. Same as any enquiry — speed still matters at stage two.
• Day 2. Two specific consultation windows. Concrete beats open-ended.
• Day 5–7. Substance rather than a prompt: what the consultation involves, how the process runs, how long the whole thing takes. This is the first message written to be forwarded to the person at home.
• Week 2–3. The payment conversation, opened lightly and without assuming it applies. This is the highest-value message in the sequence and the one most practices never send.
• Week 5–6. A call attempt from the coordinator or clinician they met. If they have consulted elsewhere by now, this is the touch that finds out where they got to.
• Month 3. A single low-pressure check-in acknowledging that this is a decision people take time over. No ask beyond a reply if anything changed.
• Month 6. The pause message: nothing is expiring, the plan is on file, here is how to pick it up. State plainly that you will not keep messaging.
• Annually, at most once. One re-open a year, and only if nothing has been declined. This is the outer edge of what is reasonable.

Six to eight touches across a year. Compare that to five touches in two weeks for a short-cycle enquiry — fewer messages per month, over far longer, which is exactly the right trade for a decision of this size.

What to send at each stage

Content matters more here than in short-cycle follow-up, because a patient in a months-long decision will read the same scheduling prompt four times and correctly conclude that the practice has nothing to say.

• Early (stages 1–2): orientation. What the consultation involves, how the assessment works, and what happens afterwards. Written so the patient knows what they are walking into. This lowers the barrier to booking more effectively than another offer of times.
• Middle (stage 3): process and duration. How the treatment runs from start to finish and roughly how long it takes. Not clinical detail and not applied to their case — the general shape of the pathway, described in operational terms. The patient is being asked at home how long this takes and does not have an answer.
• The money stage (stage 4): structure, not price. Payment options, whether the plan can be staged in phases, and what a conversation with the treatment coordinator would cover. This is where sequences are won or lost.
• Late (stage 5): logistics. Scheduling realities — lead time to get started, how appointments are spaced, what recovery time typically means for someone's work diary. Practical, not clinical.
• Throughout: something forwardable. At least one email in the sequence should be written for the person at home. That reader has all the scepticism and none of the relationship, and the patient is a poor proxy for your treatment coordinator.

Two prohibitions that apply to every message. Never imply a clinical consequence of waiting — the sequence is a scheduling and financial conversation, and nothing in it is advice about anyone's teeth. And never invent urgency: a manufactured deadline on a five-figure treatment decision does more damage here than anywhere else, because the patient is already alert to being sold to.

Financing is usually the real conversation

If you change one thing about how your practice follows up implant enquiries, make it this: raise payment structure earlier, and raise it as information rather than as a close.

The mechanism is simple. A patient who cannot see a route to paying for treatment rarely says so. Money is awkward to discuss, especially with a healthcare provider, and especially when the patient suspects the answer is that they cannot afford it. So they go quiet. From your side, that silence looks exactly like a lead who lost interest — and it is filed as one, and never contacted again, when the actual blocker was solvable and nobody named it.

• Name it before they have to. A message that says plenty of people want to understand payment options before deciding gives permission to raise the subject. Most patients will not raise it unprompted.
• Offer staging, not just borrowing. For a large plan, "we can do this in phases" is frequently a better answer than any payment plan, and far fewer practices offer it proactively.
• Capture the intent early and route the detail to a person. During intake, the system records whether a patient intends to use insurance and notes any plan details they volunteer. It never verifies coverage and never quotes out-of-pocket costs — those questions go to your team, and any vendor telling you their system handles benefits verification for a dental practice is describing something you should test extremely carefully before believing.
• Patients raise their own timing. Some will say they are waiting for a particular point in the year for reasons of their own — a benefit year, a bonus, a tax position. Record what they say and set the next touch accordingly. Do not interpret it, verify it, or advise on it.
• The financing touch is a coordinator's job, not a text message's. The sequence's role is to open the door and create the task. A person walks through it.

The parallel-consultation problem

Assume the patient is consulting other practices. For implant and full-arch work, that is normal, sensible behaviour, and a sequence written as though your practice is the only conversation reads as naive.

Two things follow. First, your follow-up is competing with other practices' follow-up — which for most competitors means nothing at all after week two, so simply still being present at month three is a meaningful position. Second, the patient is comparing plans that they may not be able to compare well: different practices describe the same work differently, and by their third consultation they have three documents and no way to line them up. A message offering to go through their questions — including questions arising from what someone else told them — is genuinely useful and is not something an automated message can do. It creates a task for a coordinator, which is the point.

What not to do: criticise other practices, ask who else they are seeing, or use a comparison as a pressure device. All three tend to lose the case, and they are the reflexes a generic sales sequence encourages.

Re-engaging a lead that went quiet months ago

Most practices have a list of implant enquiries from six, twelve, eighteen months ago that were never closed out and never contacted again. That list has real value, and working it requires more care than a marketing blast, which is exactly what it usually gets.

1. Clean the list before touching it. Remove anyone who declined, opted out, complained, or has any note suggesting a sensitive circumstance. Remove anyone already treated. This step is not optional and it is the step that gets skipped.
2. Segment by how far they got. Someone who attended a consultation and received a plan is a different conversation from someone who made one phone call. The first should hear from a person; the second can start with a message.
3. Acknowledge the gap in the first line. Pretending no time has passed is transparent. Something to the effect of: it has been a while, no assumption that this is still relevant, here is why we are getting in touch.
4. Lead with what changed, if anything real changed. A new payment option, a change in how the practice stages this work, a new clinician. If nothing has changed, say that the plan is simply still on file — which is honest and works better than a manufactured reason.
5. Give it two touches, not a sequence. One message, then one follow-up two to three weeks later, then stop. A dormant lead does not get the full long-cycle sequence again; they already had it.
6. Record the outcome properly this time. Whatever happens, the record is updated so the same list does not get re-worked from scratch next year by someone who does not know it was already tried.

Stop rules for a long sequence

A longer sequence needs stricter stop rules, not looser ones. The whole design depends on the patient believing the practice is being patient rather than persistent, and one rule breaking destroys that read.

• Any reply stops the automation and a person takes over. Any reply, not just a negative one. In a long sequence the reply is often a question about money, and that is precisely the moment a machine should hand over.
• A decline is permanent across every sequence. Not a pause, not a twelve-month suppression that quietly re-enrols them. A patient who has said no to implants does not enter the annual re-open.
• Booking any appointment stops it immediately. Including a consultation booked over the phone with your front desk. Whether that can happen automatically depends on your practice management platform and what your plan's API permits — we confirm what is possible for your setup during the audit before you commit, and if it cannot be automatic, the manual step is defined and owned by a named person rather than assumed.
• Anything clinical exits immediately. A reply mentioning pain, swelling, a failed restoration, or any symptom leaves the sequence at once and goes to a person under the same triage rule that governs your inbound calls. A patient in discomfort must never receive the next scheduled message in a marketing queue, and a patient in pain must never be routed into a consultation-booking flow.
• A hard cap, enforced in the system. Eight touches in the first year, then at most one a year. Configured as a limit that cannot be exceeded, not a guideline somebody can override.
• The annual re-open needs a reason and an owner. If nobody can say why this person is being contacted again this year, they should not be. One named person approves the list.
• Opt-out applies everywhere at once, across every sequence the practice runs, immediately.

How this gets built

1. Separate the case types first. Implant and full-arch enquiries need to be identifiable at intake, because they enter a different sequence from the moment they arrive. That is a qualification question in the intake flow, not a manual sort afterwards.
2. Write the stage content with your coordinator. The orientation, process, and payment-structure messages are practice-specific and are the substance of the sequence. Templates will not do this well.
3. Configure the caps and exits before the content. Reply detection, booking detection, the clinical exit, decline handling, and the annual cap. If those are not right, nothing should send.
4. Test the whole year internally, compressed. Your team runs the full sequence on their own phones at accelerated timing, including the reply and opt-out paths. No patient is messaged during this phase.
5. Start with new enquiries, not the dormant list. Get the live sequence reading well before touching a backlog that only gets one careful attempt.
6. Review at month three, with real transcripts. Long sequences fail slowly and quietly. Reading what actually got sent and what came back is the only way to catch it.

Questions practices ask

Go deeper